Senseera is a liquid biopsy company specializing in chromatin epigenomics. Their GEM BIOMARKERS™ platform, utilizing cfChIP-seq technology, enables the decoding of cell-specific gene expression and cell states from a simple blood draw. This innovative approach provides detailed molecular insights for diagnosing and monitoring diseases, offering the precision of biopsy-level insights with the convenience of a non-invasive test.
Leadership & Board
Current Number of Employees20
Current LinkedIn Followers1,513
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$7M
Total Amount Raised$7M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$7M
Latest Funding Amount$7M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Senseera had 20 employees as of March 23, 2026. The number of employees increased by 0 (0.00%) week-over-week.
20Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Senseera had 1,513 followers as of March 23, 2026. The number of followers increased by 17 (1.14%) week-over-week.
1,513Latest Followers Count
17(1.14%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.